VLKIM
SGNT

Van Lanschot Kempen Investment Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,219
Closed -$303K – 150
2016
Q2 		$303K Buy
+20,219
New +$260K 0.04% 131

Van Lanschot Kempen Investment Management's SGNT Position: Q3 2016 in Review

Van Lanschot Kempen Investment Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 20,219 shares — an estimated $303K sold.

Van Lanschot Kempen Investment Management first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $303K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Van Lanschot Kempen Investment Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 20,219 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $303K.
  • Van Lanschot Kempen Investment Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • Van Lanschot Kempen Investment Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $303K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.